Oxiracetam
Aliases: Ct-848, Isf 2522, Neuromet, Neuractiv, Cgp-21690e, hydroxypiracetam
Summary
Oxiracetam (ISF 2522) is a mild central nervous system stimulant and nootropic agent belonging to the racetam family of drugs. Although it is one of the first known and synthesized derivatives of piracetam, its research and efficacy in humans is limited. Oxiracetam is readily available and sold through online vendors as a dietary supplement in the United States.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 500-1200mg | 1200-1800mg | 1800-2400mg | 2400mg+ |
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | Total |
|---|---|---|---|---|---|
| Oral | 30-90 min | 30-60 min | 2-4 hrs | 2-4 hrs | 5-10.5 hrs |
Effect Profile
7 reportsScores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Strong focus and stimulation with low euphoria and anxiety/jitters
Tolerance
Tolerance Decay
Tolerance appears to build gradually with frequent daily use and decays over weeks after cessation, based on user patterns with racetams generally; consider cycling (e.g., 5 days on, 2 off, or 2–4 weeks on, 1–2 weeks off) to maintain effect and reduce escalation. Data are anecdotal.
Cross-Tolerances
Effects
Aggregated from 7 Erowid experience reports